XML 54 R39.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock Based Compensation (Tables)
12 Months Ended
Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
Roll Forward Schedule of Stock Option Plan by Shares and Weighted Average Exercise Prices

 
Stock Option Plans
Roll Forward of Shares Outstanding:
 
Outstanding at January 1, 2016
421,751

Granted
56,650

Exercised
(111,992
)
Forfeited
(10,758
)
Outstanding at December 31, 2016
355,651

Exercisable at Period-End
224,039

Vested and Expected to Vest
131,612

 
 
Roll Forward of Shares Outstanding - Weighted Average Exercise Price:
 
Outstanding at January 1, 2016
$
21.93

Granted
25.10

Exercised
21.47

Forfeited
23.97

Outstanding at December 31, 2016
22.52

Exercisable at Period-End
21.40

Vested and Expected to Vest
24.44

 
 
Weighted Average Remaining Contractual Life (in years):
 
Outstanding at December 31, 2016
5.59

Exercisable at December 31, 2016
4.05

Vested and Expected to Vest
8.21

 
 
Aggregate Intrinsic Value:
 
Outstanding at December 31, 2016
$
6,395

Exercisable at December 31, 2016
4,279

Vested and Expected to Vest
2,116

 
 
Shares Available for Grant at Period-End
367,775

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range
Schedule of Shares Authorized Under the Stock Option Plan by Exercise Price Range
 
Exercise Price Ranges
 
$17.82 to $18.54
$20.78
$22.18 to $22.80
23.33
$24.61 to $25.10
Total
Outstanding at December 31, 2016
 
 
 
 
 
 
Number of Shares Outstanding
51,254

40,305

100,747

59,912

103,433

355,651

Weighted-Average Remaining Contractual Life (in years)
1.71

3.08

4.58

7.05

8.61

5.59

Weighted-Average Exercise Price
$
18.32

$
20.78

$
22.46

$
23.33

$
24.87

$
22.52

 
 
 
 
 
 
 
Exercisable at December 31, 2016
 
 
 
 
 
 
Number of Shares Outstanding
51,254

40,305

98,555

25,134

8,791

224,039

Weighted-Average Remaining Contractual Life (in years)
1.71

3.08

4.56

7.01

8.08

4.05

Weighted-Average Exercise Price
$
18.32

$
20.78

$
22.46

$
23.33

$
24.61

$
21.40

Other Stock Based Compensation Disclosure Table
Schedule of Other Stock Option Plan Information
 
 
2016
 
2015
 
2014
Shares Granted
 
56,650

 
57,258

 
77,784

Weighted Average Grant Date Information:
 
 
 
 
 
 
Fair Value of Options Granted
 
$
5.60

 
$
5.50

 
$
5.63

Fair Value Assumptions:
 
 
 
 
 
 
Dividend Yield
 
3.88
%
 
3.90
%
 
3.97
%
Expected Volatility
 
32.95
%
 
33.55
%
 
35.30
%
Risk Free Interest Rate
 
1.80
%
 
1.57
%
 
2.19
%
Expected Lives (in years)
 
7.56

 
7.66

 
6.85

 
 
 
 
 
 
 
Amount Expensed During the Year
 
$
287

 
$
308

 
$
360

Compensation Costs for Non-vested Awards Not Yet Recognized
 
521

 
500

 
478

Weighted Average Expected Vesting Period, In Years
 
2.71

 
2.12

 
1.68

Proceeds From Stock Options Exercised
 
$
2,404

 
$
917

 
$
1,454

Tax Benefits Related to Stock Options Exercised
 
188

 
59

 
25

Intrinsic Value of Stock Options Exercised
 
1,010

 
250

 
170

Schedule of Employee Stock Ownership Plan (ESOP) Disclosures
Schedule of ESOP Compensation Expense
 
 
2016
 
2015
 
2014
ESOP Compensation Expense
 
$
1,200

 
$
900

 
$
800


Shares pledged as collateral are reported as unallocated ESOP shares in stockholders equity.  As shares are released from collateral, Arrow reports compensation expense equal to the current average market price of the shares, and the shares become outstanding for earnings per share computations.  The ESOP shares as of December 31, 2016 were as follows:

Schedule of Shares in ESOP Plan
ESOP Plan Shares:
2016
Allocated Shares
713,814

Shares Released for Allocation During 2016
36,927

Unallocated Shares
19,466

Total ESOP Shares
770,207

 
 
Market Value of Unallocated Shares
$
789